A detailed history of Evergreen Capital Management LLC transactions in Royalty Pharma PLC stock. As of the latest transaction made, Evergreen Capital Management LLC holds 257,309 shares of RPRX stock, worth $6.25 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares
257,309
Previous 298,317 13.75%
Holding current value
$6.25 Million
Previous $7.87 Million 7.46%
% of portfolio
0.26%
Previous 0.3%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$25.63 - $29.27 $1.05 Million - $1.2 Million
-41,008 Reduced 13.75%
257,309 $7.28 Million
Q2 2024

Aug 14, 2024

BUY
$26.26 - $29.9 $1.29 Million - $1.47 Million
49,284 Added 19.79%
298,317 $7.87 Million
Q1 2024

May 15, 2024

BUY
$27.46 - $31.33 $179,368 - $204,647
6,532 Added 2.69%
249,033 $7.56 Million
Q4 2023

Feb 14, 2024

SELL
$26.21 - $29.22 $154,665 - $172,427
-5,901 Reduced 2.38%
242,501 $6.81 Million
Q3 2023

Nov 14, 2023

SELL
$26.26 - $31.38 $16,648 - $19,894
-634 Reduced 0.25%
248,402 $6.74 Million
Q2 2023

Aug 14, 2023

BUY
$29.6 - $36.56 $1.36 Million - $1.68 Million
46,074 Added 22.7%
249,036 $7.66 Million
Q1 2023

May 15, 2023

BUY
$32.77 - $39.4 $3.18 Million - $3.82 Million
97,025 Added 91.59%
202,962 $7.31 Million
Q4 2022

Feb 14, 2023

SELL
$39.17 - $44.04 $626 - $704
-16 Reduced 0.02%
105,937 $4.19 Million
Q3 2022

Nov 14, 2022

BUY
$39.88 - $44.65 $638 - $714
16 Added 0.02%
105,953 $4.26 Million
Q2 2022

Aug 15, 2022

SELL
$37.53 - $44.22 $473,591 - $558,012
-12,619 Reduced 10.64%
105,937 $4.45 Million
Q1 2022

May 16, 2022

BUY
$37.46 - $42.44 $1.27 Million - $1.44 Million
33,852 Added 39.97%
118,556 $4.62 Million
Q4 2021

Mar 11, 2022

BUY
$35.17 - $42.48 $2.98 Million - $3.6 Million
84,704 New
84,704 $3.38 Million

Others Institutions Holding RPRX

About Royalty Pharma plc


  • Ticker RPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 437,139,008
  • Market Cap $10.6B
  • Description
  • Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...
More about RPRX
Track This Portfolio

Track Evergreen Capital Management LLC Portfolio

Follow Evergreen Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Evergreen Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Evergreen Capital Management LLC with notifications on news.